Marinus Pharmaceuticals, Inc. - Common Stock (MRNS)

Historical Holders from Q3 2020 to Q1 2025

Symbol
MRNS
CUSIP
56854Q200
Type / Class
Equity / Common Stock
Shares outstanding
54.7M
All holders as of March 31, 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-50
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marinus Pharmaceuticals, Inc. - Common Stock (MRNS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 5.5% +42.5% $1.66M $505K 3.02M +43.6% SUVRETTA CAPITAL MANAGEMENT, LLC Feb 7, 2025
VANGUARD GROUP INC 4.7% $1.43M 2.6M The Vanguard Group Dec 31, 2024
TANG CAPITAL PARTNERS LP 3% $903K 1.64M TANG CAPITAL MANAGEMENT, LLC Dec 31, 2024

Institutional Holders of Marinus Pharmaceuticals, Inc. - Common Stock (MRNS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$15.8M 0
2024 Q4 29.5M $15.8M -$30.4M $0.54 50
2024 Q3 41.4M $72.9M -$1.83M $1.76 73
2024 Q2 43.3M $50.6M -$154M $1.17 86
2024 Q1 53.8M $486M +$383K $9.04 118
2023 Q4 20.6K $224K $10.87 1
2023 Q3 51.1M $411M +$48.3M $8.05 102
2023 Q2 44.7M $485M +$47.9M $10.86 104
2023 Q1 41.1M $284M +$27.6M $6.90 85
2022 Q4 36.2M $144M +$42.8M $3.98 71
2022 Q3 25.2M $168M +$2.29M $6.65 63
2022 Q2 28.6M $140M -$7.03M $4.84 63
2022 Q1 30M $280M -$1.23M $9.35 81
2021 Q4 29.9M $355M -$20.7M $11.88 71
2021 Q3 31.8M $362M -$2.7M $11.38 78
2021 Q2 31.4M $563M +$3.86M $17.94 78
2021 Q1 31M $480M +$23.8M $15.48 86
2020 Q4 29.2M $356M +$128M $12.20 80
2020 Q3 18.6M $238M +$238M $12.85 69